Astec LifeSciences Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Astec LifeSciences stock has a consensus rating of "Hold" and an average price target of ₹755.00. The average 1-year stock price forecast is 4.04% lower than the current stock price, while the lowest is ₹600.00 (-23.74%) and the highest is ₹910.00 (+15.66%).

Price Target: ₹755.00 (-4.04%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	₹600.00	₹755.00	₹755.00	₹910.00
Change	-23.74%	-4.04%	-4.04%	+15.66%

Analyst Ratings

The average analyst rating for Astec LifeSciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

6.39B

from 4.48B

42.61%

from 4.48B

Revenue Next Year

7.69B

from 6.39B

20.34%

from 6.39B

EPS This Year

9.70

from -36.81

EPS Next Year

17.60

from 9.70

81.44%

from 9.70

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	6.77B	6.28B	4.59B	3.81B	4.48B	6.39B
Revenue Growth	21.16%	-7.15%	-27.03%	-16.86%	17.53%	42.61%
Gross Profit	2.85B	2.22B	1.34B	757.20M	1.50B	2.43B
Gross Margin	42.09%	35.26%	29.16%	19.86%	33.41%	38.00%
Operating Income	1.20B	434.56M	-415.94M	-1.10B	-494.48M	530.00M
Net Income	898.59M	255.65M	-469.30M	-1.35B	-809.18M	216.00M
EPS	-	-	-	-	-36.81	9.70
Forward PE	-	-	-	-	-	81.11
Dividend / Share	1.50	1.50	1.50	-	-	-
Free Cash Flow	-1.49B	-673.05M	-1.34B	-230.84M	-934.97M	252.00M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	6.4B
Avg	6.4B
Low	6.4B

Revenue Growth

Revenue Growth	2027	2028	2029
High	42.6%
Avg	42.6%
Low	42.6%

EPS Forecast

EPS	2027	2028	2029
High	9.70
Avg	9.70
Low	9.70

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-